drugset / Trial / NCT00566982

A Clinical Study to Evaluate the Safety of Ospemifene

NCT00566982

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the efficacy and long-term safety of 60mg ospemifene in the treatment of VVA in postmenopausal women with intact uterus.

Timeline

Start
2007-10
Primary completion
2009-07
Completion
2009-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Ospemifene Other / unclassified 60 mg Oral

Indications